Analysis 1.2.
Comparison 1 Human‐derived botulinum immune globulin intravenous, Outcome 2 In‐hospital death from any cause occurring within 4 weeks of randomization or the beginning of treatment.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.